Journal article icon

Journal article

Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1136/annrheumdis-2019-215183

Authors


Publisher:
BMJ Publishing Group Publisher's website
Journal:
Annals of the Rheumatic Diseases Journal website
Volume:
78
Issue:
10
Pages:
1439-1441
Publication date:
2019-04-24
Acceptance date:
2019-04-11
DOI:
ISSN:
1468-2060
Keywords:
Pubs id:
pubs:987916
UUID:
uuid:249fefcd-2997-4c34-9b50-d34d93b1533e
Local pid:
pubs:987916
Source identifiers:
987916
Deposit date:
2019-04-12

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP